A nearly debt-free, cash-generous blue-chip consumer company with a long, reliable dividend record — but sliding revenue and a payout that lately exceeds profit are the things to watch.
Unilever Consumer Care is a small-float, high-quality consumer-goods company backed by the global Unilever group, built for steady dividends rather than fast growth. It carries almost no debt and huge accumulated reserves, but its sales have been shrinking and it has recently paid out more in dividends than it earned. It suits patient, income-focused investors who value stability — as long as they keep an eye on the softening revenue and cash flow.
Value today
Around fair valueToday
৳2,062
Rough estimate
৳1,904
Based on its own past price levels, what similar companies trade at, the value of what it owns and the dividend it pays. · low confidence
- Its own usual price vs profit৳2,318
- Priced like similar companies (profit)৳1,885
- Its own usual price vs asset value৳2,320
- Based on the dividend it pays৳700
A rough, educational estimate from the figures we have — not a price target or advice.
Data as of 2026-07-16
What does this company do?
A long-listed, blue-chip consumer company under the global Unilever name — small in share count but big in reserves.
Unilever Consumer Care Limited is a consumer-goods company in the 'Food & Allied' group on the Dhaka Stock Exchange, listed all the way back in 1976 — about 50 years on the market. It carries the Unilever name, tying it to one of the world's largest consumer-products groups.
By share count it is a small company: only about 1.93 crore shares exist, and its paid-up capital is just 19.3 crore taka. But behind those few shares sit large accumulated profits — reserves of about 204.9 crore taka, more than ten times the paid-up capital. It sits in the exchange's top 'A' category.
Ownership is tightly held. The sponsor (the parent group) owns 92.8% of the shares, leaving only a small slice trading freely — about 3.55% with the general public and 3.54% with institutions.
How does it make money?
It earns by selling everyday branded consumer products, and keeps a large share of each sales taka as profit.
The company makes its money selling everyday branded consumer products — the kind of goods households buy again and again. That regular, repeat buying is what drives its sales.
Its yearly revenue has stayed in the 300–400 crore taka range: about 414.4 crore taka in 2021, 409.9 crore in 2022, 395.4 crore in 2023, and 338.3 crore in 2024. The trend across those years has been gently downward — the top line has been shrinking rather than growing.
What stands out is how much of that revenue turns into profit. In 2023, for example, it turned 395.4 crore taka of sales into 106.8 crore taka of operating profit — a very healthy slice. That profitability slipped in 2024 (66.7 crore taka of operating profit on 338.3 crore of sales), which is worth watching.
Is it actually making money?
Profit is up about 50% since 2020 but bumpy — and profit per share has actually slipped as more shares split the pie.
Net profit has grown over the long run, but not in a straight line: 52.9 crore taka in 2020, 52.8 in 2021, 73.0 in 2022, 96.2 in 2023, then down to 66.7 in 2024, and back up to 79.4 crore taka in 2025. From 2020 to 2025, net profit rose about 50%.
Profit per share tells a more sobering story. It was 43.94 taka in 2020, jumped to 60.64 taka in 2022, then fell to 34.62 taka in 2024 and recovered to 41.21 taka in 2025. Over 2020–2025, profit per share actually fell about 6% — even though total profit rose. The reason: the company handed out a 60% stock (bonus) dividend in 2022, so the same profit is now split across more shares, and each share's slice got smaller.
So the company is clearly profitable, but the earnings are lumpy from year to year, and shareholders have not seen their per-share earnings grow over this stretch.
Is it financially safe?
One of the safest balance sheets around — almost no debt and big reserves — but cash and cash flow have been draining.
On safety, the company is very strong. It carries essentially no bank loans (total borrowing is zero), and what little debt it has is tiny next to its own money — its debt was just 0.05 times its equity in 2024, down from 0.13 in 2021. Its own capital has grown steadily, from about 148 crore taka in 2021 to 244.4 crore in 2024, backed by reserves of around 204.9 crore taka.
The worry is cash. The company's cash pile shrank from about 376 crore taka in 2021 to 229.6 crore in 2022, 243.3 in 2023, and just 106.7 crore taka by 2024. Alongside that, the cash actually generated by the business (its operating cash flow) fell from 66.3 crore taka in 2021 to almost nothing — about 0.05 crore taka — in 2024.
A debt-free company with big reserves can absorb a bad year comfortably, so the risk of it going under is very low. But the steady drain in cash, and the near-zero cash generation in 2024, mean this strength is being tested — and it is closely tied to the large dividends discussed below.
How do we judge if it's fairly priced?
We judge the price four ways — its own past pricing, similar companies, asset value, and dividend — but the live estimate carries the verdict.
There is no single 'right price' for a share; instead you compare today's price against a few sensible yardsticks. Four are used here: how the share has usually been priced against its profit in the past, what similar companies' shares cost for the profit they make, the value of what the company owns per share, and how much dividend it pays for the price.
The durable inputs behind those yardsticks: the company earned 41.21 taka of profit per share in 2025, it owns net assets worth about 116.3 taka per share, and it pays 42 taka per share in dividend. Historically, investors have been willing to pay a high price for each taka of this company's profit — the mark of a premium, blue-chip name.
Whether the share is cheap, fair, or expensive today depends on the current price, which moves every day. That answer is not written here; it is shown in the live 'value today' estimate beside this report — so the report never goes stale.
Value today
Around fair valueToday
৳2,062
Rough estimate
৳1,904
Based on its own past price levels, what similar companies trade at, the value of what it owns and the dividend it pays. · low confidence
- Its own usual price vs profit৳2,318
- Priced like similar companies (profit)৳1,885
- Its own usual price vs asset value৳2,320
- Based on the dividend it pays৳700
A rough, educational estimate from the figures we have — not a price target or advice.
Does it reward shareholders?
A generous, every-year dividend payer — but lately it has paid out as much as or more than it earns.
Dividends are this company's calling card. It has paid a cash dividend every year in the record: 440% in 2020 and 2021, 240% cash plus a 60% stock dividend in 2022, 300% in 2023, 520% in 2024, and 420% for 2025. On a face value of 10 taka, the 2025 dividend of 420% means 42 taka in cash for every share.
In taka-per-share terms the payouts were 44, 44, 24, 30, 52 and 42 taka across 2020–2025 — large and consistent. Big reserves of about 204.9 crore taka stand behind these payments, which is reassuring.
The caution is affordability. In 2024 the company paid 52 taka per share while earning only 34.62 taka; in 2025 it paid 42 taka while earning 41.21 taka. Paying out as much as, or more than, it earns cannot continue forever — it draws down the cash reserves, which is part of why the cash pile has been shrinking. The dividend is generous and reliable so far, but its size relative to profit is the thing to watch.
What makes it special?
Its edge is a trusted brand, fat margins, no debt, and a global parent — but shrinking sales are the honest weak spot.
The company's real advantage shows up in its numbers. It keeps an unusually large share of its sales as profit — turning 395.4 crore taka of 2023 sales into 106.8 crore taka of operating profit — which points to strong brands and pricing power. It also earns a strong return on its owners' money, well above several Food & Allied peers in the fact pack such as Apex Foods and the PRAN marketing company, whose returns on capital are in the low single digits.
It is also backed by the global Unilever group, which owns 92.8% of the shares, and it runs with essentially no debt and decades of retained profit (reserves of 204.9 crore taka against just 19.3 crore of paid-up capital). That combination — brand, backing, and a clean balance sheet — is a genuine, durable edge.
The honest weakness is growth. Revenue has drifted down from 414.4 crore taka in 2021 to 338.3 crore in 2024, and operating profit fell in 2024. A strong brand whose sales are not growing is protected but not expanding — so the edge here is more about defending profits than winning new ground.
Why it could do well
Safe balance sheet, fat margins, a generous dividend, and deep parent backing.
- Rock-solid balance sheet: no bank loans at all, with debt as low as 0.05 times equity in 2024 — very little can go financially wrong.
- Highly profitable brand: keeps a large share of sales as profit (106.8 crore taka of operating profit on 395.4 crore of sales in 2023), and net profit rose about 50% from 2020 to 2025.
- Generous, unbroken dividend: paid every year, 420% (42 taka per share) for 2025, cushioned by reserves of about 204.9 crore taka.
- Deep backing: part of the global Unilever group, which holds 92.8% of the shares — long-term commitment and know-how.
- Decades of retained profit: reserves of 204.9 crore taka dwarf the 19.3 crore paid-up capital, a sign of long, steady money-making.
What could go wrong
Shrinking sales and cash, flat per-share earnings, a dividend bigger than profit, and a tiny free float.
- Shrinking sales: revenue slid from 414.4 crore taka in 2021 to 338.3 crore in 2024 — the business is getting smaller, not bigger.
- Flat-to-lower earnings per share: profit per share fell about 6% over 2020–2025 and is bumpy (60.64 taka in 2022 down to 34.62 in 2024), partly because a 2022 stock dividend added shares.
- Draining cash: the cash pile fell from about 376 crore taka in 2021 to 106.7 crore in 2024, and cash generated by the business was almost zero (0.05 crore taka) in 2024.
- Dividend bigger than profit: it paid 52 taka per share in 2024 (earning 34.62) and 42 taka in 2025 (earning 41.21) — a payout above earnings cannot last indefinitely.
- Tiny free float: with the sponsor holding 92.8%, only about 3.55% is with the public and 3.54% with institutions, so very few shares trade — the stock can be thin and hard to buy or sell in size.
So, is it for you?
A dependable, dividend-first blue-chip for patient income seekers — if you accept slow growth and watch the payout.
Unilever Consumer Care is a high-quality, conservative business: a strong brand, almost no debt, big reserves, a global parent, and a long history of paying dividends every year. For an investor who wants steadiness and regular income more than rapid growth, this is the kind of company that fits.
The trade-offs are real. Sales have been shrinking, profit per share has not grown over five years, cash generation weakened sharply in 2024, and the dividend has lately been as large as or larger than yearly profit. None of these threaten the company's survival — its balance sheet is very safe — but they cap how exciting the growth story can be and put a question mark over how long the biggest payouts can hold.
In short: a steady-income, long-term holding for conservative investors, not a fast-growth pick — with the softening revenue, weaker cash flow, and the size of the dividend as the main things to keep watching. Whether today's price is attractive is a separate question, answered by the live value estimate shown beside this report.
This is educational information, not investment advice. Always do your own research or consult a licensed adviser before investing.